Navigate regulatory and reimbursement to get DTx to market
We’re seeing unprecedented levels of innovation, but how much of that innovation is transforming patient lives?
Our brand new DTx track, in partnership with the Digital Therapeutics Alliance (DTA), focusses on the real issues – the evolving regulatory and reimbursement essentials that will make the difference between hype and impact.
Below is the full agenda for the Digital Therapeutics Conference (April 1st).
If you’re an executive from a biopharma company, you can attend for FREE, sign-up for a Free Expo Pass here (biopharma companies only) >>>
Spaces are limited. Apply today.
SIGN-UP FOR FREE FOR THIS CONFERENCE. (FOR BIO AND PHARMA ONLY)
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.